Article successfully added.

CyFlow™ CD70 Purified

CyFlow™ CD70 Purified
Alternative Name: CD27L, Ki-24 , TNFSF7
Antibody: Yes
Antigen: CD70
Application: Flow cytometry
Clonality: monoclonal
Clone: Ki-24
Field of Interest: Immunophenotyping
Format/Fluorochrome: Purified
Isotype: IgG3
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: BR463667

For Research Use Only

$120.00 USD*

Price excludes any applicable taxes plus shipping costs

Description Documentation TDS & SDS
Description
Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 mL... more
Close menu
CyFlow™ CD70 Purified
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenNot available
Background InformationCD70 (TNFSF7, CD27L) is a 50 kDa type II transmembrane glycoprotein of the TNF superfamily. It is expressed mainly on activated lymphocytes, including NK cells, and forms trimeric structure. CD70 plays a role in T-cell activation, proliferation and differentiation, in enhancing the generation of cytolytic T cells, and in long-term maintenance of T cell memory. It is also involved in B cell differentiation induced by activated plasmacytoid dendritic cells, which also express CD70.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Israel BF, Pickles RJ, Segal DM, Gerard RD, Kenney SC: Enhancement of adenovirus vector entry into CD70‑positive B‑cell Lines by using a bispecific CD70‑adenovirus fiber antibody. J Virol. 2001 Jun; 75(11):5215‑21. < PMID: 11333903 > | Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low‑grade lymphoma. J Immunol. 2005 Nov 15; 175(10):6940‑7. < PMID: 16272354 > | Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low‑grade lymphoma. J Immunol. 2005 Nov 15; 175(10):6940‑7. < PMID: 16272354 > | Hashimoto-Okada M, Kitawaki T, Kadowaki N, Iwata S, Morimoto C, Hori T, Uchiyama T: The CD70‑CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans. Int Immunol. 2009 Aug; 21(8):891‑904. < PMID: 19556308 > | Trebing J, El-Mesery M, Schäfer V, Weisenberger D, Siegmund D, Silence K, Wajant H: CD70‑restricted specific activation of TRAILR1 or TRAILR2 using scFv‑targeted TRAIL mutants. Cell Death Dis. 2014 Jan 30; 5:e1035. < PMID: 24481449 >

TDS & SDS
Close menu

Technical Data Sheet

Safety Data Sheet